David Jones Jr
David is founder and managing director of Chrysalis Ventures, a leading provider of early and growth stage equity in middle America, where he currently focuses on the potential of digital and business model innovation to transform healthcare, education and human capital management. Since 1993 David has served as a director of Humana Inc., including chairing the company’s board from 2005 – 2010.
At Chrysalis, David has worked over the years with some of the most exciting growth companies in the Midwest and South, including Appriss (sold to Bain Capital), Advanced Academics (sold to Devry), Tritel (merged with Telecorp and sold to AT&T Wireless), Regent Communications (sold to Jacor Communications which was sold to Clear Channel Communications), ActaMed (merged with Healtheon and then with WebMD), Tech Republic (sold to Gartner Group), High Speed Access Corp (IPO and later sold to Charter Communications) and HCCA International (sold to Windrose and rebranded Shearwater Health).
David brings a strong and well-rounded background in business, law and banking to his work at Chrysalis Ventures. Prior to Chrysalis, David’s law practice included both domestic and international work, the latter with the U.S. Department of State general counsel’s office in Washington (1988-1992). Before law school, he worked as a commercial banker for Bank of Boston in Hong Kong, New York and Boston, and taught English at a Chinese medical university (1980-82).
David has a BA from Yale University and a JD from Yale University Law School. He currently serves as adjunct professor of innovation at Bellarmine University, and lectures frequently in Chrysalis’ region on topics related to venture capital, the changing healthcare industry, and innovation in public education.
David is active in civic and charitable affairs on both national and local levels. He served on term as an elected member of the Jefferson County (Louisville) Board of Education (2013-2016), including two years as chair. An active philanthropist, David also serves as a director of the Humana Foundation and of an independent private foundation.